Save your place

Sign in to WhoBought

Please try again later.

Terns Pharmaceuticals, Inc. (TERN) institutional ownership

Market cap$478M SectorHealthcare
Funds holding · Q1 2026
346
reported TERN position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Activity unavailable N/A
234 buyers · 112 sellers

Terns Pharmaceuticals, Inc. (TERN) price and institutional activity

Dates

Q1 2026

$0 bought by 234 investors
Hbk Investments L PGlazer Capital, LLC +232 more
$0 sold by 112 investors
Vivo Capital, LLCVestal Point Capital, LP +110 more
Sign in to see who bought
Bought Sold Totals per quarter; hover a bar for the names.

Terns Pharmaceuticals, Inc. (TERN) institutional activity · 346

Investor Type Est. change Change Δ Own Date
Vivo Capital, LLC · Reduced
Change −4.0M Date Q1 2026
Vivo Capital, LLC Reduced· Q1 2026 −4.0M Q1 2026
Vestal Point Capital, LP · Reduced
Change −3.5M Date Q1 2026
Vestal Point Capital, LP Reduced· Q1 2026 −3.5M Q1 2026
Adage Capital Partners Gp, L.L.C. · Reduced
Change −3.4M Date Q1 2026
Adage Capital Partners Gp, L.L.C. Reduced· Q1 2026 −3.4M Q1 2026
Hbk Investments L P · New
Change +3.0M Date Q1 2026
Hbk Investments L P New· Q1 2026 +3.0M Q1 2026
Glazer Capital, LLC · New
Change +2.3M Date Q1 2026
Glazer Capital, LLC New· Q1 2026 +2.3M Q1 2026
Orbimed Advisors LLC · Exited
Change −2.2M Δ Own −100.0% Date Q1 2026
Orbimed Advisors LLC Exited· Q1 2026 −2.2M −100.0% Q1 2026
Millennium Management LLC · Added
Change +2.0M Date Q1 2026
Millennium Management LLC Added· Q1 2026 +2.0M Q1 2026
Janus Henderson Group PLC · Reduced
Change −1.9M Date Q1 2026
Janus Henderson Group PLC Reduced· Q1 2026 −1.9M Q1 2026
Balyasny Asset Management L.P. · Added
Change +1.9M Date Q1 2026
Balyasny Asset Management L.P. Added· Q1 2026 +1.9M Q1 2026
Ameriprise Financial Inc · Reduced
Change −1.8M Date Q1 2026
Ameriprise Financial Inc Reduced· Q1 2026 −1.8M Q1 2026
Morgan Stanley · Reduced
Change −1.5M Date Q1 2026
Morgan Stanley Reduced· Q1 2026 −1.5M Q1 2026
Commodore Capital LP · Exited
Change −1.5M Δ Own −100.0% Date Q1 2026
Commodore Capital LP Exited· Q1 2026 −1.5M −100.0% Q1 2026
Paradigm Biocapital Advisors LP · Added
Change +1.4M Date Q1 2026
Paradigm Biocapital Advisors LP Added· Q1 2026 +1.4M Q1 2026
Woodline Partners LP · Exited
Change −1.4M Δ Own −100.0% Date Q1 2026
Woodline Partners LP Exited· Q1 2026 −1.4M −100.0% Q1 2026
BlackRock · Added
Change +1.4M Date Q1 2026
BlackRock Added· Q1 2026 +1.4M Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 346

Famous investor activity in Terns Pharmaceuticals, Inc. (TERN)

Terns Pharmaceuticals, Inc. (TERN) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Azelby Robert · Director 2 operations -92K
Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Azelby Robert Director 2 operations -92K 0 May 5, 2026 May 5, 2026
Turner Heather D. · Director 3 operations -111K
Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Turner Heather D. Director 3 operations -111K 0 May 5, 2026 May 5, 2026
Tripuraneni Radhika · Director 7 operations -190K
Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Tripuraneni Radhika Director 7 operations -190K 0 May 5, 2026 May 5, 2026
Quigley Jill M. · Director 7 operations -147K
Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Quigley Jill M. Director 7 operations -147K 0 May 5, 2026 May 5, 2026
Kindler Jeffrey B. · Director 9 operations -209K
Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Kindler Jeffrey B. Director 9 operations -209K 0 May 5, 2026 May 5, 2026
Fellows David A. · Director 9 operations -221K
Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Fellows David A. Director 9 operations -221K 0 May 5, 2026 May 5, 2026
Kuriakose Emil · Officer Other Form 4 events -$1.3M
Price $53.00 Qty -25K Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Kuriakose Emil Officer Other Form 4 events $53.00 -25K -$1.3M 0 May 5, 2026 May 5, 2026
Kuriakose Emil · Officer 6 operations -1.2M
Price $53.00 Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Kuriakose Emil Officer 6 operations $53.00 -1.2M 0 May 5, 2026 May 5, 2026
Gengos Andrew · CFO Other Form 4 events -$2.1M
Price $53.00 Qty -41K Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Gengos Andrew CFO Other Form 4 events $53.00 -41K -$2.1M 0 May 5, 2026 May 5, 2026
Gengos Andrew · CFO 3 operations -956K
Price $53.00 Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Gengos Andrew CFO 3 operations $53.00 -956K 0 May 5, 2026 May 5, 2026
Burroughs Amy L. · Director 2 operations -$8.2M
Price $53.00 Qty -155K Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Burroughs Amy L. Director 2 operations $53.00 -155K -$8.2M 0 May 5, 2026 May 5, 2026
Burroughs Amy L. · Director 4 operations -2.7M
Price $53.00 Owned 0 Trade date May 5, 2026 Filed date May 5, 2026
Burroughs Amy L. Director 4 operations $53.00 -2.7M 0 May 5, 2026 May 5, 2026
Kuriakose Emil · Officer Sell −$50K
Price $52.75 Qty −942 Owned 106K Trade date Apr 1, 2026 Filed date Apr 2, 2026
Kuriakose Emil Officer Sell $52.75 −942 −$50K 106K Apr 1, 2026 Apr 2, 2026
Burroughs Amy L. · Director, Officer 2 operations −$681K
Price $46.57–$47.30 Qty −15K Owned 292K Trade date Mar 16, 2026 Filed date Mar 17, 2026
Burroughs Amy L. Director, Officer 2 operations $46.57–$47.30 −15K −$681K 292K Mar 16, 2026 Mar 17, 2026
Burroughs Amy L. · Director, Officer 2 operations 0
Price $4.64 Owned 956K Trade date Mar 16, 2026 Filed date Mar 17, 2026
Burroughs Amy L. Director, Officer 2 operations $4.64 0 956K Mar 16, 2026 Mar 17, 2026
15 of 35
15 of 35 Sign in to continue to older insider transactions.

Terns Pharmaceuticals, Inc. (TERN) activist and large shareholders

What are Schedules 13D and 13G?

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
Orbimed Advisors LLC 7.6M
% of shares outstanding 9.0% Filing date Sep 16, 2024
Orbimed Advisors LLC 7.6M 9.0% Sep 16, 2024
Soleus Capital Master Fund, L.P. 6.2M
% of shares outstanding 7.3% Filing date Nov 14, 2024
Soleus Capital Master Fund, L.P. 6.2M 7.3% Nov 14, 2024
Deep Track Capital, LP 5.6M
% of shares outstanding 6.4% Filing date May 15, 2025
Deep Track Capital, LP 5.6M 6.4% May 15, 2025
Blackrock, Inc. 4.7M
% of shares outstanding 5.6% Filing date Nov 8, 2024
Blackrock, Inc. 4.7M 5.6% Nov 8, 2024
Venrock Healthcare Capital Partners Iii, L.P. 35.2M
% of shares outstanding 5.0% Filing date Nov 14, 2024
Venrock Healthcare Capital Partners Iii, L.P. 35.2M 5.0% Nov 14, 2024
Schonfeld Strategic Advisors LLC 4.3M
% of shares outstanding 4.9% Filing date May 15, 2025
Schonfeld Strategic Advisors LLC 4.3M 4.9% May 15, 2025
BlackRock Inc. 3.1M
% of shares outstanding 4.8% Filing date Jun 7, 2024
BlackRock Inc. 3.1M 4.8% Jun 7, 2024
Citadel Advisors LLC 3.3M
% of shares outstanding 3.9% Filing date Feb 14, 2025
Citadel Advisors LLC 3.3M 3.9% Feb 14, 2025
8 of 16

Terns Pharmaceuticals, Inc. (TERN) ownership FAQ

Who owns TERN?

346 reporting institutions disclosed TERN position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.